Gut Microbiome Clinical Trial
Official title:
The Influence of Oral Probiotics on the Microbiome and Lipidome
The purpose of this study is to measure oil production of the face, facial properties, and gut bacteria in people being given oral probiotics. Probiotic supplements contain active cultures of bacteria that are thought to be beneficial to human health.The investigators want to find out if probiotics taken by mouth alter the bacteria in subject's gut and subject's skin oil production compared to a placebo. This is a single blind study and subject may receive a probiotic or a placebo for the first half of the study and a placebo or a probiotic for the second half of the study. Subject will not know what was given to participants.
Antibiotics are widely used within dermatology for the treatment of chronic skin conditions
such as acne, rosacea, and atopic dermatitis. Previous studies have shown that oral
probiotics may be beneficial for skin disesaes such as atopic dermatitis and acne, but a
mechanism for how the gut communicates to the skin remains elusive.
The balance between short chain fatty acids and long chain fatty acids has been proposed as
one factor in how bacteria in the gut are able to communicate with the rest of the body.
Studies in Dr. Sivamani's lab have shown that subjects with acne have a reduced level of
short chain fatty acids in their blood when compared to age-matched control (unpublished).
The aim of this study is to understand how oral probiotics may alter the gut microbiome and
if they can augment the short chain fatty acids in the blood lipidome. Ultimately, the
investigator's goal is to find suitable alternatives for the use of antibiotics in the
treatment of chronic skin conditions so that the amount of antibiotics that are in use can be
reduced.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05793112 -
INF108F in Infants With Food Protein Induced Proctocolitis
|
Phase 4 | |
Active, not recruiting |
NCT04327141 -
Low Sugar Protein Pacing, Intermittent Fasting Diet in Men and Women
|
N/A | |
Recruiting |
NCT04117321 -
Mother-infant Microbiota Transmission and Its Link to the Health of the Baby
|
||
Recruiting |
NCT05655910 -
Enhanced Nutritional Optimization in LVAD Trial
|
N/A | |
Recruiting |
NCT03325855 -
Fecal Microbiota Transplant National Registry
|
||
Active, not recruiting |
NCT05931471 -
Yogurt and GI Health
|
N/A | |
Recruiting |
NCT03797417 -
Gut Microbiome and Metabolic Pathways Changes in Vitiligo
|
||
Withdrawn |
NCT06006416 -
Effect of Fenugreek Fibre on Gut Microbiome
|
Phase 3 | |
Recruiting |
NCT06206486 -
The Gut Microbiome and Serum Metabolites as a Biological Mechanism Underlying Pain in Kidney Transplantation
|
||
Completed |
NCT02655250 -
Neonatal Microbiome Validity Study
|
||
Recruiting |
NCT05670288 -
Impact of Gut Microbiome on Metabolic and Bowel Function During the First Year After Spinal Cord Injury
|
||
Not yet recruiting |
NCT03975764 -
Fecal Microbiota in Preterm Birth
|
||
Completed |
NCT03219931 -
NEOBIFI: Clinical Trial for the Prevention and/or Reduction of the Incidence of Colics in Infants
|
Phase 4 | |
Recruiting |
NCT04447365 -
The Correlation Between Gut Microbiome-host Interaction and Ventricular Arrhythmias.
|
||
Recruiting |
NCT04466072 -
Gut Microbiome and Ventricular Arrhythmias
|
||
Not yet recruiting |
NCT06130137 -
Gut Microbiome in People Living With HIV and HBV
|
||
Recruiting |
NCT06260579 -
Home-based Exercise and Physical Activity Intervention After Kidney Transplantation: Impact of Exercise Intensity
|
N/A | |
Completed |
NCT04511052 -
Probiotics for Enhanced Tissue Carotenoid Status in Premenopausal Women
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT06424691 -
Infant Restore: Efficacy of Microbiome Analysis and Education
|
N/A | |
Recruiting |
NCT06404749 -
Fungal Fiber for Gut Health
|
N/A |